`571.272.7822
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper No. 98
`
` Filed: December 10, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. And
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner and Licensee.
`____________
`
`Case IPR2017-001901
`Patent 7,214,506 B2
`____________
`
`
`
`Before Eric W. Hawthorne, Supervisory Trial Paralegal
`
`
`
`NOTIFICATION OF RECEIPT OF POP REQUEST
`
`The Office has received a request for Precedential Opinion Panel (POP)
`review of an issue raised in this case. See Ex. 3001. The request is under review.
`The Office will provide another notification after a decision on the request has
`been made.
`
`
`1 Case IPR2017-01429 has been joined.
`
`
`
`IPR2017-00190
`Patent 7,214,506 B2
`
`
`
`
`For PETITIONER:
`
`Tara Raghavan
`traghavan@rmmslegal.com
`
`Steven J. Birkos (Reg. No. 65,300)
`sbirkos@rmmslegal.com
`
`
`FOR PATENT OWNER:
`
`John Livingstone
`john.livingstone@finnegan.com
`
`Naoki Yoshida
`naoki.yoshida@finnegan.com
`
`Toan Vo
`toan.vo@bausch.com
`
`Anthony Hartmann
`hartmana@finnegan.com
`
`Trenton A. Ward
`trenton.ward@finnegan.com
`
`Barbara R. Rudolph
`barbara.rudolph@finnegan.com
`
`
`
`
`
`2
`
`